Details of the Drug

General Information of Drug (ID: DM4UZRE)

• Drug Name: TPIV200

Indication

Disease Entry	ICD 11	Status	REF
Breast cancer	2C60-2C65	Phase 2	[1]
Ovarian cancer	2C73	Phase 2	[1]
Triple negative breast cancer	2C60-2C65	Phase 2	[2]

• Cross-matching ID: TTD ID: D0LB8Z
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [2] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)